Filed Oct. 2, 2026

Serial No. 50141274

Class Scientific research and development; Scientific research for medical purposes in the field of central nervous system disorders, metabolic disorders, or cancer; Research and development in the field of pharmaceuticals and medical treatment; Scientific research in the field of pharmaceuticals and medical treatment; Medical and scientific research in the field of central nervous system disorders, metabolic disorders, and cancer; Providing medical and scientific research information; Medical research; Providing information about medical and scientific research; Medical research in the field of central nervous system disorders, metabolic disorders, and cancer; Research and development in the field of pharmaceuticals; Development of pharmaceutical preparations and medicines; Laboratory research in the field of pharmaceuticals; Research and development of new products in the field of pharmaceuticals; Research and development in the field of pharmaceuticals; Conducting early evaluations in the field of new pharmaceuticals; Pharmaceutical research and development; Pharmaceutical products development; Pharmaceutical research in the field of central nervous system disorders, metabolic disorders, and cancer; Research and development in the field of small molecule kinase inhibitors; Research and development in the field of treatments for central nervous system disoders; Research and development in the field of treatments for metabolic disorders; Research and development in the field of treatment of cancer; Research and development services in the field of pharmaceutical preparations; Research and development of medicines; 100; 101

Case Type Service mark